What Kratom Strain Names Mean (and Why They Don’t Always Predict Experience)

Where did kratom strain names come from?

Kratom strain names emerged informally through the trade routes between Southeast Asian farmers, regional distributors, and eventually Western importers beginning in the early 2000s. There was no governing body, botanical authority, or industry standard involved. Names developed from three separate traditions: processing color (red, green, white), geographic association (Bali, Borneo, Malay, Thai), and trade grade labels (Maeng Da, Elephant, Horn).^[2]

By the mid-2010s, the US kratom market had codified dozens of named strains across vendor catalogs, with names often applied inconsistently. The same leaf from the same Indonesian supplier might be labeled “Red Bali” by one vendor and “Red Borneo” by another — both names technically accurate as marketing categories, neither meaningful as botanical identifiers.^[3]

In my decade running Amazing Botanicals, I’ve sourced from the same family farms in Indonesia for years. The leaf that becomes our Green Maeng Da and the leaf that becomes our Red Bali often begins on the same trees — differentiated by harvest timing and what happens in the 48 hours after picking. That context is essential for understanding what the name actually represents.

What do the vein colors actually mean scientifically?

Vein color is the most scientifically meaningful component of a kratom strain name — but it still has significant limitations. The color does not refer to the vein color of the leaf in the field (all mature kratom leaves have similar vein coloration). Instead, it refers to the processing method applied after harvest, which affects the leaf’s final alkaloid ratio.^[1]

Standard processing approaches by color:

• Green: Harvested at moderate leaf maturity. Dried indoors or in shade for shorter periods, limiting UV-driven oxidation. Retains higher mitragynine as a proportion of total alkaloids — typically 55–67% of the alkaloid fraction.
• Red: Extended drying with UV light exposure (sunlight or UV lamp), or fermentation (Bentuangie-style). The UV/oxidative process drives partial conversion of mitragynine to secondary alkaloids (speciogynine, speciociliatine, paynantheine), shifting the alkaloid ratio. Red products tend toward lower MG% with more secondary alkaloid content.
• White: Often harvested at younger leaf maturity and dried entirely indoors. Alkaloid profile varies widely by vendor — some whites are nearly indistinguishable from greens on HPLC analysis.

Boffa et al. (2018) measured alkaloid profiles across multiple commercial samples and found that while color categories show tendencies, there is substantial overlap.^[1] A red-labeled product from one vendor may test at higher mitragynine than a green-labeled product from another. The color is a reliable indicator of processing intent — not a guarantee of alkaloid content.

Do regional names (Bali, Borneo, Malay) indicate geographic origin?

Rarely with any precision. The geographic names attached to kratom strains evolved from early trade relationships between Southeast Asian exporters and Western importers in the 2000s. At that time, some geographic names did roughly indicate sourcing regions — “Borneo” kratom came broadly from Kalimantan or Borneo, “Malay” from Peninsular Malaysia, “Thai” from southern Thailand.^[2]

As the market expanded and consolidated, the names increasingly decoupled from actual geography:

• “Bali” kratom almost universally does not come from Bali island. Bali is a major export hub — the port through which much Indonesian kratom ships — so the name stuck as an origin label even though the leaf itself originates from Kalimantan, Sumatra, or Java.
• “Thai kratom” rarely comes from Thailand. Thailand had a national ban on kratom from 1943 until 2021, meaning commercial Thai-origin leaf was functionally unavailable during the period when the US market grew. Most “Thai” kratom is Indonesian leaf processed in the style traditionally associated with Thai-region kratom.
• “Malay” has similar issues — Malaysia’s kratom export market is smaller and less organized than Indonesia’s, and much “Malay” leaf originates from Indonesian farms.

Indonesia is the dominant source of the vast majority of kratom sold in the US and Europe, regardless of the geographic label on the package. The AKA GMP program requires vendor transparency about sourcing, but geographic names remain commercial tradition, not verified origin claims.^[4]

What does “Maeng Da” actually mean?

“Maeng Da” (แมงดา) is a Thai phrase meaning roughly “pimp” or “pimp grade” — colloquially used in Thailand to mean something of top quality or high potency. In the kratom context, it originally referred to a particularly potent, carefully selected and blended kratom that was marketed to experienced users seeking stronger effects.^[3]

In current commercial usage, Maeng Da has largely lost its specific meaning. It is now one of the most common strain name prefixes in the US market, applied by vendors to products across all vein colors (Green Maeng Da, Red Maeng Da, White Maeng Da). There is no industry standard defining what alkaloid content, leaf origin, or processing method qualifies as Maeng Da.^[2]

Across the batches we test at Amazing Botanicals, our Green Maeng Da consistently runs 1.4–1.7% mitragynine on HPLC. But a “Maeng Da” product from a different vendor with no COA requirement could be anywhere from 0.4% to 2%+ mitragynine. The name doesn’t standardize the product — only third-party testing does.

What are yellow and gold kratom?

Yellow and gold are not standard botanical or processing categories — they are vendor-defined terms with inconsistent usage across the industry. Several distinct practices generate products sold as “yellow” or “gold”:^[1]

• Blending: Some vendors blend red, green, and white in specific ratios and label the result gold or yellow. The alkaloid profile reflects the blend ratio.
• Extended fermentation: A subset of vendors apply a longer fermentation process than standard red processing, producing a distinctly colored leaf with an altered secondary alkaloid profile. Often described as a smoother, more sedating experience.
• Late-harvest greens: Leaves harvested at peak maturity (before the red processing phase) sometimes produce a yellowish-green powder, which some vendors market as yellow or gold.

Without a COA, “gold” or “yellow” kratom is essentially undefined. With a COA, you can see whether it tests similarly to a standard green, a standard red, or falls between — giving you the actual alkaloid data that the name cannot provide.

What does lab data show about same-named strains?

The most directly relevant published evidence on kratom strain name reliability comes from Boffa et al. (2018), which used HPLC chromatography to quantify alkaloid profiles across six commercially available kratom products from different suppliers.^[1]

Their findings illustrate the problem with strain names as predictors:

• Mitragynine content ranged from 12.2 mg/g to 66.3 mg/g across the six strains — more than a 5× range across commercial products
• Green Malay had the highest mitragynine percentage at 59.7% of identified alkaloids
• White Borneo showed 12.2 mg/g total density — lower than the Green products
• Red Bali contained 24 identifiable alkaloids vs. 11 found in other strains — illustrating that processing method genuinely shifts alkaloid complexity, not just total MG

The takeaway from Boffa’s data: the color category (green/red/white) does carry some signal — reds tend toward more secondary alkaloids and lower MG%, greens tend toward higher MG%. But the geographic component of the name (Malay vs. Bali vs. Borneo) tells you almost nothing about the alkaloid profile once batch and vendor sourcing variability is factored in.^[1]

Are there actual genetic differences between kratom strains?

This is one of the most common misconceptions about kratom strain names. The answer is: no confirmed genetically distinct subspecies exist. Mitragyna speciosa is a single species. The commercial strain system does not map to botanical taxonomy.

Brown et al. (2017), in a comprehensive botanical, phytochemical, and ethnomedicinal review of the genus Mitragyna, documented that while leaf morphology and alkaloid content vary across plants from different regions, no formal subspecies or chemotype classification has been validated.^[2] The variation observed in alkaloid profiles across commercial strains is attributable to:

• Agro-climatic differences: Soil composition, rainfall, altitude, and temperature affect alkaloid synthesis in the plant. These are real botanical variables — but they don’t create discrete, nameable subspecies.
• Leaf maturity at harvest: Mitragynine concentration increases as the leaf matures, peaking at full maturity and declining in very old leaves. Harvesting a tree’s leaves at different stages produces meaningfully different alkaloid ratios from the same genetic material.^[5]
• Post-harvest processing: As covered above, drying method, UV exposure, and fermentation drive the largest predictable differences between color categories.
• Storage and transit: Alkaloids degrade during storage. A fresh batch and a six-month-old batch of the “same” strain can test at meaningfully different alkaloid levels.

Genetic research into Mitragyna speciosa populations is still early-stage. Some studies have identified chemotypic variation across geographic populations, but this has not been translated into a validated, commercially relevant taxonomy that corresponds to current strain names.^[2]

green kratom powder showing fine alkaloid-rich texture” style=”width:100%;border-radius:6px;” loading=”lazy” />

What actually predicts kratom’s effects?

Given that strain names are unreliable predictors, what does matter? Survey data from Grundmann (2017), which collected self-reported outcomes from 8,049 US kratom users, provides useful context on what users identify as driving consistent outcomes.^[3]

In practice, the most reliable predictors of kratom’s effects are:

1. Mitragynine percentage on the COA — the single strongest predictor of alkaloid potency. A verified 1.6% MG product is consistently more potent than a verified 0.8% MG product from the same vendor. This number is what the strain name is trying — and often failing — to approximate.
2. Dose by gram weight — effects are dose-dependent. The same product produces stimulant effects at 1–3g and opioid-adjacent effects at 5–8g. Dose variation is a stronger predictor than strain name variation for most users.^[6]
3. Color processing category — red vs. green is a meaningful broad predictor because of the underlying processing differences. Not perfect, but the most reliable component of the strain name system.
4. Vendor consistency and COA program — AKA GMP-qualified vendors test every batch. The COA for a batch tells you more than the strain name. We publish COAs for every product at our lab testing page.^[4]
5. Individual pharmacokinetics — CYP2D6 genetic polymorphism, body composition, tolerance level, food timing, and hydration state contribute substantially to individual variation. Two people taking the same batch of the same strain at the same dose will have different experiences based on biology alone.^[7]

Frequently asked questions about kratom strain names

Is Maeng Da a real strain or just a marketing term?

Maeng Da is a trade grade label, not a distinct botanical strain. The term originated in Thailand as a quality indicator meaning roughly “top grade” or “pimp grade.” As the US market grew, it became one of the most widely used strain name prefixes — applied inconsistently across vendors with no standardized alkaloid specification. Green Maeng Da from one vendor may test at 1.7% mitragynine; Green Maeng Da from another may test at 0.9%. The COA tells you what you’re actually buying; the name does not.^[3]

Does Red Bali actually come from Bali?

Almost never. Bali is a major Indonesian export hub — much Indonesian kratom ships through Bali’s ports — which is how the name became attached to a broad category of Indonesian kratom. The leaf in most commercial “Bali” kratom originates from Kalimantan (Borneo), Sumatra, or Java. The name is a trade tradition, not a verified geographic origin label. This is widely understood in the industry but rarely disclosed in product descriptions.^[2]

Why does the same strain name feel different from two different vendors?

Because the name doesn’t standardize anything about the product. Two vendors selling “Green Maeng Da” may source from completely different farms, use different processing methods, purchase from different distributors, and have different quality control standards. Mitragynine percentage can vary by 2–3× across same-named products from different vendors. Without a COA from each batch, the strain name provides no basis for potency comparison. Always compare COA mitragynine percentages when evaluating products across vendors.^[1]

Are there genetic differences between red, green, and white kratom?

No. Red, green, and white kratom can all come from the same tree — and often do. The color designation reflects post-harvest processing method (drying duration, UV exposure, fermentation), not the plant’s genetics. A farmer can harvest leaves from one Mitragyna speciosa tree and process them three different ways to produce three different color products. The genetic material is identical; the alkaloid ratio differs based on what happens after harvest.^[2]

Is green kratom always more stimulating than red?

By tendency, yes — but not universally. Green processing preserves a higher mitragynine-to-secondary-alkaloid ratio. At low doses (1–3g), higher mitragynine content correlates with more stimulant-like effects via adrenergic pathways. Red processing shifts toward more secondary alkaloids (speciogynine, paynantheine) associated with more sedating effects. But batch variation, dose, individual pharmacokinetics, and tolerance all interact with this tendency. A high-dose green can produce the same opioid-receptor-mediated sedation as a moderate-dose red.^[6]

What are yellow and gold kratom strains?

Yellow and gold are vendor-defined terms with no standardized meaning across the industry. They typically indicate one of three things: a proprietary blend of red/green/white leaf in specific ratios; an extended fermentation process beyond standard red processing; or late-harvest green leaf that produces a yellowish powder. Without a COA, “gold” and “yellow” labels tell you nothing about alkaloid content. With a COA, you can assess whether the alkaloid profile aligns with green-like or red-like characteristics.^[1]

What should a beginner look for instead of strain names?

Start with color category and a COA, in that order. For first-time users, a green vein powder from an AKA GMP-qualified vendor gives you the most predictable experience — greens tend toward moderate effects at low doses without the pronounced sedation of reds. Look for a COA showing mitragynine content between 1.2–1.6% (a reasonable starting range). Start at 1–2g and assess before increasing. The strain name beyond the color component matters far less than these two factors.^[4]

Do strain names matter at all?

The color component matters — moderately. Red vs. green is a meaningful broad category based on real processing differences that genuinely shift alkaloid ratios. Within-color strain variation (Red Bali vs. Red Borneo vs. Red Maeng Da) matters much less and is largely vendor convention. The most useful thing a strain name can do is give you a vocabulary for tracking what you’ve tried and communicating with other users — not serve as a reliable potency or effect predictor.^[3]

How do I compare kratom products reliably across strain names?

Compare COA mitragynine percentages from the same lab, or from labs using the same HPLC method. A product at 1.8% MG will be more potent per gram than one at 0.9% MG, regardless of what strain name is on the label. AKA GMP-qualified vendors publish COAs for every batch. At Amazing Botanicals, you can view the COA for any product on our lab testing page before purchasing. This is the only method that allows reliable cross-product comparison.^[4]

What happened to Thai kratom after Thailand lifted its ban?

Thailand decriminalized kratom in August 2021, removing kratom from its Schedule 5 narcotics list. This opened the possibility of legal kratom cultivation and export from Thailand. However, as of 2026, the Thai export market remains small and regulatory frameworks are still developing. The vast majority of commercial kratom in the US still originates from Indonesia. “Thai kratom” sold in the US market today is almost entirely Indonesian-origin leaf processed in a style traditionally associated with Thai-region kratom.^[8]

Related guides

References

1. Boffa, L., Ghè, C., Barge, A., Muccioli, G., & Cravotto, G. (2018). Alkaloid profiles and activity in different Mitragyna speciosa strains. Natural Product Communications, 13(9), 1934578X1801300921. [DOI]
2. Brown PN, Lund JA, Murch SJ (2017). A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom. Journal of ethnopharmacology, 202, 302-325. [PubMed]
3. Grundmann O (2017). Patterns of Kratom use and health impact in the US-Results from an online survey. Drug and alcohol dependence, 176, 63-70. [PubMed]
4. American Kratom Association. (2023). AKA Good Manufacturing Practices (GMP) Standards Program. [AKA GMP]
5. Alrashedy NA, Molina J (2016). The ethnobotany of psychoactive plant use: a phylogenetic perspective. PeerJ, 4, e2546. [PubMed]
6. Smith KE, Rogers JM, Dunn KE, et al. (2022). Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories. Frontiers in pharmacology, 13, 765917. [PubMed]
7. Trakulsrichai S, Sathirakul K, Auparakkitanon S, et al. (2015). Pharmacokinetics of mitragynine in man. Drug design, development and therapy, 9, 2421-9. [PubMed]
8. Kruegel AC, Grundmann O (2018). The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology, 134(Pt A), 108-120. [PubMed]